Improved human interferon molecules and their uses

Details for Australian Patent Application No. 2006255122 (hide)

Owner Ambrx, Inc.

Inventors Kraynov, Vadim; Hays Putnam, AnnaMaria A.; Miao, Zhenwei; Knudsen, Nick; Bussell, Stuart; Kimmel, Bruce E.; Mariani, Roberto; Koder, Alan; Sim, Bee-Cheng; Liu, Junjie; Morrow, Theresa; Litzinger, David C.; Daniel, Thomas O.; Cho, Ho Sung

Agent FB Rice

Pub. Number AU-B-2006255122

PCT Pub. Number WO2006/133089

Priority 60/687,173 03.06.05 US; 60/753,375 21.12.05 US

Filing date 2 June 2006

Wipo publication date 14 December 2006

Acceptance publication date 21 October 2010

International Classifications

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/133089 Priority application(s): WO2006/133089

21 October 2010 Application Accepted

  Published as AU-B-2006255122

17 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006255125-Methods of treating cancer and other conditions or disease states using LFMAU and LDT

2006255120-A catalyst, a process for preparing the catalyst, and a process for the production of an olefin oxide, a 1,2-diol, a 1,2-diol ether, or an alkanolamine